ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,548Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 1171

$1.5M Total Retail Price of All Prescriptions

Rank: 14 out of 1171

927 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 927 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 927 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 25,477 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 903 849 1 4
FUROSEMIDE 882 819 2 6
SIMVASTATIN 878 841 3 1
LISINOPRIL 767 738 4 3
OMEPRAZOLE 744 655 5 5
AMLODIPINE BESYLATE 701 668 6 2
WARFARIN SODIUM 691 645 7 12
METOPROLOL TARTRATE 655 617 8 11
HYDROCODONE-ACETAMINOPHEN 622 410 S3 9 8
TRAMADOL HCL 585 543 10 18
VENLAFAXINE HCL ER 552 494 11 113
TRAZODONE HCL 529 493 12 37
DONEPEZIL HCL 497 491 13 24
QUETIAPINE FUMARATE 476 396 14 54
SERTRALINE HCL 427 336 15 23
POTASSIUM CHLORIDE 404 363 16 19
ATORVASTATIN CALCIUM 397 385 17 10
GABAPENTIN 374 317 18 16
METFORMIN HCL 346 314 19 7
MIRTAZAPINE 320 304 20 50
HYDROCHLOROTHIAZIDE 318 309 21 9
PREDNISONE 296 261 22 39
METOPROLOL SUCCINATE 271 261 23 17
LANTUS 268 241 24 46
NAMENDA 260 254 25 42
ADVAIR DISKUS 247 229 26 51
DIVALPROEX SODIUM 230 202 27 106
BUSPIRONE HCL 228 207 28 129
OXYCODONE HCL 224 175 S2 29 79
MELOXICAM 218 212 30 56
ALLOPURINOL 218 212 30 31
SEROQUEL 206 176 32 120
HUMALOG 203 189 33 132
RISPERIDONE 202 167 34 77
LEVETIRACETAM 200 111 35 84
POLYETHYLENE GLYCOL 3350 192 178 36 72
DOXAZOSIN MESYLATE 191 191 37 82
TAMSULOSIN HCL 189 183 38 28
SPIRONOLACTONE 184 152 39 53
ATENOLOL 183 157 40 15
NITROFURANTOIN MONO-MACRO 180 170 41 210
PANTOPRAZOLE SODIUM 175 156 42 29
RANITIDINE HCL 173 163 43 38
ALENDRONATE SODIUM 171 149 44 33
NEXIUM 168 134 45 25
CIPROFLOXACIN HCL 164 146 46 61
BACLOFEN 156 110 47 110
VENLAFAXINE HCL 151 149 48 300
CYMBALTA 150 96 49 64
LOSARTAN POTASSIUM 149 147 50 14
CITALOPRAM HBR 148 132 51 22
PROMETHAZINE HCL 148 89 R 51 87
OXYCODONE-ACETAMINOPHEN 147 100 S2 53 59
NYSTATIN 145 125 54 128
FLUOXETINE HCL 144 129 55 76
ISOSORBIDE MONONITRATE ER 141 141 56 44
KLOR-CON M20 138 137 57 41
AZITHROMYCIN 137 119 58 43
DIOVAN 137 129 58 32
PRAVASTATIN SODIUM 135 128 60 13
FLUTICASONE PROPIONATE 134 111 61 30
TRIAMCINOLONE ACETONIDE 132 114 62 133
CARVEDILOL 125 117 63 20
ZOLPIDEM TARTRATE 123 92 64 21
LIDODERM 122 114 65 98
CLOPIDOGREL 116 116 66 35
PROAIR HFA 113 94 67 49
FINASTERIDE 109 109 68 88
PHENYTOIN SODIUM EXTENDED 107 57 69 137
CEPHALEXIN 101 90 70 104
FENTANYL 95 95 S2 71 89
AMITRIPTYLINE HCL 93 75 R 72 74
CARBIDOPA-LEVODOPA 89 89 73 107
CLOTRIMAZOLE-BETAMETHASONE 89 84 73 174
SPIRIVA 84 82 75 57
CEFTRIAXONE 83 69 76 232
OXYBUTYNIN CHLORIDE 82 80 77 171
AMIODARONE HCL 81 79 78 192
GLIMEPIRIDE 80 71 79 34
DIGOXIN 80 80 79 68
GLYBURIDE 78 78 R 81 97
ESCITALOPRAM OXALATE 76 76 82 69
IPRATROPIUM-ALBUTEROL 75 74 83 130
TRIAMTERENE-HCTZ 74 62 84 58
CILOSTAZOL 72 72 85 271
AVELOX 69 68 86 209
FLOVENT HFA 69 61 86 370
CRESTOR 69 53 86 27
NOVOLOG 68 67 89 94
PROPRANOLOL HCL 66 49 90 134
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 62 91 26
BRIMONIDINE TARTRATE 64 63 91 257
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 57 93 109
CYCLOBENZAPRINE HCL 62 51 R 93 67
COMBIVENT 61 54 95 152
AMLODIPINE BESYLATE-BENAZEPRIL 61 60 95 70
AMOXICILLIN 60 49 97 111
KLOR-CON 10 60 47 97 126
TIZANIDINE HCL 59 30 99 158
DOXYCYCLINE HYCLATE 58 57 100 137
DILTIAZEM 24HR ER 58 51 100 112
ALBUTEROL SULFATE 57 56 102 102
PLAVIX 57 57 102 55
GLIPIZIDE 57 55 102 47
ISOSORBIDE DINITRATE 56 56 105 213
TERAZOSIN HCL 54 53 106 143
LOSARTAN-HYDROCHLOROTHIAZIDE 54 52 106 40
LATANOPROST 54 54 106 188
OXYCODONE HCL-ACETAMINOPHEN 53 30 S2 109 99
FLUDROCORTISONE ACETATE 53 41 109 372
LIPITOR 52 51 111 92
BUPROPION HCL SR 52 38 111 224
CARBAMAZEPINE 51 51 113 193
SINGULAIR 50 48 114 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.